In the current study, our results demonstrated that Guttiferone K significantly inhibited the production of proinflammatory mediators that have been proved to participate in the process of pathological damage caused by uncontrolled inflammation during TB [39–41] and restraining the activation of NLRP3 inflammasome. Here, NLRP3 is linked to tuberculosis.